Table 5 Changes over time in 8 countries where two country situational analyses were done
From: Promoting quality use of medicines in South-East Asia: reports from country situational analyses
Country (Years of country situational analyses) | % URTI cases treated with antibioticsa | % patients treated with antibioticsa | % medicines prescribed from the EMLa | % medicines prescribed by generic namea | % patients prescribed multivitaminsa | % of patients prescribed injectionsa | Average % better (+) medicines use over time (95% CI) | Change in the number of policies implemented between the second and first situation analyses |
|---|---|---|---|---|---|---|---|---|
Direction of better medicines use: More (+); Less (−) | Less (−) | Less (−) | More (+) | More (+) | Less (−) | Less (−) | Sign (+/−) changed for QUM indicators where less use is better use so that “+” = better QUM | |
Bangladesh (2010, 2014) | −16.6 | 0 | ||||||
Bhutan (2011, 2015) | −19.6 | + 8.1 | + 1.5 | + 2.9 | − 10.1 | −3.7 | + 4.9 (−2.4 to + 12.5) | + 2 |
Maldives (2011, 2014) | − 19.3 | −13.8 | + 19.3 | + 22.8 | + 5.6 | + 4.8 (− 10.0 to + 19.6) | + 3 | |
Myanmar (2011, 2014) | + 2.0 | + 7.1 | −7.6 | + 11.3 | + 13.7 | + 4.0 | − 3.8 (− 10.6 to + 2.9) | + 4 |
Nepal (2011, 2014) | − 6.3 | −2.5 | −0.04 | −10.5 | + 11.7 | −3.7 | − 1.6 (− 7.8 to + 4.5) | 0 |
Sri Lanka (2010, 2015) | + 7.1 | − 7.5 | + 13.4 | −7.8 | + 1.7 (− 6.8 to + 10.1) | + 2 | ||
Thailand (2012, 2015) | −13.7 | − 17.9 | + 8.4 | + 5.0 | − 2.5 | + 1.3 | + 7.7 (+ 2.0 to + 13.4)** | + 7 |
Timor-Leste (2012, 2015) | −24.1 | −13.7 | −3.7 | −6.4 | − 17.9 | + 0.1 | + 7.6 (− 2.5 to + 17.7) | −1 |